\-\ Texto\\:\\ \ \(0\)\
\-\ alk\\ phos\\ \\-\\ 210\ \(0\)\
\-\ ast\\/alt\\-\\ 17\\/132\ \(0\)\
\-\ tb\\ \\-\\ 21\\.7\ \(0\)\
\-\ db\\ \\-\\ 12\\.8\ \(0\)\
\-\ ammonia\\-\\ 45\ \(0\)\
\-\ the\\ patient\\ expired\\ secondary\\ to\\ his\\ metastatic\\ pancreatic\\ cancer\\.\ \(0\)\
\-\ single\\ contrast\\ enhanced\\ axial\\ image\\ at\\ the\\ level\\ of\\ the\\ kidneys\\ demonstrates\\ air\\ within\\ the\\ biliary\\ system\\.\\ \\ also\\ identified\\ is\\ a\\ biliary\\ stent\\.\\ no\\ significant\\ biliary\\ dilitation\\ is\\ noted\\.\ \(0\)\
\-\ pneumobilia\ \(2\)\
\-\ portal\\ venous\\ gas\\ vs\\.\\ biliary\\ gas\ \(0\)\
\-\ portal\\ venous\\ gas\\ tends\\ to\\ extend\\ to\\ the\\ periphery\\ of\\ the\\ liver\\ as\\ opposed\\ to\\ biliary\\ air\\ which\\ is\\ more\\ central\\ in\\ its\\ location\ \(0\)\
\-\ 82\\ y\\/o\\ male\\ with\\ pancreatic\\ cancer\\ and\\ biliary\\ obstruction\\ who\\ is\\ status\\ post\\ biliary\\ stent\\ placement\\ in\\ xs\\ 2\\ in\\ 2002\\ who\\ presents\\ with\\ reobstruction\\ of\\ the\\ biliary\\ tree\\.\\ \\ exam\\ performed\\ to\\ evaluate\\ tumor\\ progression\\ and\\ extent\\ of\\ involvement\\ in\\ the\\ biliary\\ tree\\.\ \(0\)\
\-\ when\\ air\\ is\\ present\\ in\\ the\\ biliary\\ tree\\ on\\ radiographic\\ examination\\ thought\\ should\\ be\\ given\\ to\\ whether\\ the\\ patient\\ has\\ had\\ surgery\\ or\\ other\\ procedure\\ involving\\ the\\ biliary\\ tree\\.\\ \\ this\\ can\\ cause\\ abnormal\\ communication\\ between\\ the\\ biliary\\ tree\\ and\\ the\\ bowel\\ therefore\\ allowing\\ air\\ into\\ the\\ biliary\\ system\\.\ \(0\)\
\-\ patients\\ with\\ penetrating\\,\\ gallstones\\,\\ crohn\\'s\\ disease\\,\\ some\\ malignancies\\ and\\ duodenal\\ ulcers\\ are\\ prone\\ to\\ pneumobilia\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ biliary\\:\\ 0\\.7021362072125735\ \(0\)\
\-\ tree\\:\\ 0\\.3059010194225626\ \(0\)\
\-\ pneumobilia\\:\\ 0\\.17164598232572062\ \(0\)\
\-\ the\\:\\ 0\\.16224279900310332\ \(0\)\
\-\ gas\\:\\ 0\\.15258036353500273\ \(0\)\
\-\ air\\:\\ 0\\.15195434734452554\ \(0\)\
\-\ stent\\:\\ 0\\.11719271504092685\ \(0\)\
\-\ portal\\:\\ 0\\.11115990094240942\ \(0\)\
\-\ pancreatic\\:\\ 0\\.10530187626318312\ \(0\)\
\-\ to\\:\\ 0\\.10163663037032998\ \(0\)\
\-\ xs\\:\\ 0\\.09288021453352562\ \(0\)\
\-\ reobstruction\\:\\ 0\\.09288021453352562\ \(0\)\
\-\ system\\:\\ 0\\.08861573030724423\ \(0\)\
\-\ 210\\:\\ 0\\.08355107268794747\ \(0\)\
\-\ venous\\:\\ 0\\.0829310074597482\ \(0\)\
\-\ is\\:\\ 0\\.07952600127161653\ \(0\)\
\-\ cancer\\:\\ 0\\.07736881620147334\ \(0\)\
\-\ in\\:\\ 0\\.07224026791867422\ \(0\)\
\-\ db\\:\\ 0\\.0699588645794247\ \(0\)\
\-\ dilitation\\:\\ 0\\.06846623286525999\ \(0\)\
\-\ expired\\:\\ 0\\.06801365074925292\ \(0\)\
\-\ tends\\:\\ 0\\.06716470747170401\ \(0\)\
\-\ opposed\\:\\ 0\\.06601086039716313\ \(0\)\
\-\ allowing\\:\\ 0\\.06601086039716313\ \(0\)\
\-\ who\\:\\ 0\\.06570560489745858\ \(0\)\
\-\ malignancies\\:\\ 0\\.06530841491556469\ \(0\)\
\-\ gallstones\\:\\ 0\\.06290164120875939\ \(0\)\
\-\ prone\\:\\ 0\\.06212799668764544\ \(0\)\
\-\ penetrating\\:\\ 0\\.06118020388451253\ \(0\)\
\-\ ulcers\\:\\ 0\\.06118020388451253\ \(0\)\
\-\ communication\\:\\ 0\\.06095642737858761\ \(0\)\
\-\ alk\\:\\ 0\\.060737463645694545\ \(0\)\
\-\ phos\\:\\ 0\\.0601074841010387\ \(0\)\
\-\ 82\\:\\ 0\\.05913709101968183\ \(0\)\
\-\ periphery\\:\\ 0\\.058596357520463424\ \(0\)\
\-\ duodenal\\:\\ 0\\.056976852872862416\ \(0\)\
\-\ whether\\:\\ 0\\.056828216347535446\ \(0\)\
\-\ crohn\\:\\ 0\\.05653729880874085\ \(0\)\
\-\ 2002\\:\\ 0\\.05557995047120471\ \(0\)\
\-\ extend\\:\\ 0\\.05357249936318124\ \(0\)\
\-\ progression\\:\\ 0\\.05325595300213123\ \(0\)\
\-\ extent\\:\\ 0\\.05315258743249035\ \(0\)\
\-\ tb\\:\\ 0\\.05171620680704193\ \(0\)\
\-\ therefore\\:\\ 0\\.05119396817423408\ \(0\)\
\-\ thought\\:\\ 0\\.050146733813727494\ \(0\)\
\-\ kidneys\\:\\ 0\\.04999476948279506\ \(0\)\
\-\ and\\:\\ 0\\.048004869374441046\ \(0\)\
\-\ 45\\:\\ 0\\.046569003933341326\ \(0\)\
\-\ procedure\\:\\ 0\\.04630315537928855\ \(0\)\
\-\ of\\:\\ 0\\.045462845664131\ \(0\)\
\-\ placement\\:\\ 0\\.04535186440702338\ \(0\)\
\-\ evaluate\\:\\ 0\\.04516243715396765\ \(0\)\
\-\ single\\:\\ 0\\.04465898343637662\ \(0\)\
\-\ vs\\:\\ 0\\.04430786515362212\ \(0\)\
\-\ enhanced\\:\\ 0\\.044221945477830524\ \(0\)\
\-\ radiographic\\:\\ 0\\.04308951044306219\ \(0\)\
\-\ its\\:\\ 0\\.04297532508371093\ \(0\)\
\-\ involvement\\:\\ 0\\.04203594667870927\ \(0\)\
\-\ identified\\:\\ 0\\.04117596513347468\ \(0\)\
\-\ obstruction\\:\\ 0\\.04068072240819428\ \(0\)\
\-\ involving\\:\\ 0\\.04068072240819428\ \(0\)\
\-\ status\\:\\ 0\\.04053077240532446\ \(0\)\
\-\ location\\:\\ 0\\.040441851131291985\ \(0\)\
\-\ liver\\:\\ 0\\.04006525492846258\ \(0\)\
\-\ given\\:\\ 0\\.039952126862813964\ \(0\)\
\-\ cause\\:\\ 0\\.03956579353369863\ \(0\)\
\-\ central\\:\\ 0\\.03878422675476623\ \(0\)\
\-\ should\\:\\ 0\\.037896237711754946\ \(0\)\
\-\ patient\\:\\ 0\\.0377800609429262\ \(0\)\
\-\ between\\:\\ 0\\.03773661529760376\ \(0\)\
\-\ bowel\\:\\ 0\\.03727223547325542\ \(0\)\
\-\ examination\\:\\ 0\\.03716472210716522\ \(0\)\
\-\ image\\:\\ 0\\.037143355003500744\ \(0\)\
\-\ some\\:\\ 0\\.036542445710321975\ \(0\)\
\-\ his\\:\\ 0\\.035223228876764164\ \(0\)\
\-\ level\\:\\ 0\\.035082793254948896\ \(0\)\
\-\ when\\:\\ 0\\.035082793254948896\ \(0\)\
\-\ abnormal\\:\\ 0\\.03489280363225236\ \(0\)\
\-\ secondary\\:\\ 0\\.034424609827279046\ \(0\)\
\-\ performed\\:\\ 0\\.034359448509441594\ \(0\)\
\-\ with\\:\\ 0\\.03411750727768659\ \(0\)\
\-\ axial\\:\\ 0\\.03354824798425666\ \(0\)\
\-\ significant\\:\\ 0\\.03353326428595365\ \(0\)\
\-\ patients\\:\\ 0\\.032672349906309205\ \(0\)\
\-\ more\\:\\ 0\\.031891325355696644\ \(0\)\
\-\ metastatic\\:\\ 0\\.03185316882949134\ \(0\)\
\-\ post\\:\\ 0\\.031602382230207\ \(0\)\
\-\ surgery\\:\\ 0\\.031225474648300684\ \(0\)\
\-\ into\\:\\ 0\\.030873547176318124\ \(0\)\
\-\ noted\\:\\ 0\\.03079315200606748\ \(0\)\
\-\ can\\:\\ 0\\.030477773038375316\ \(0\)\
\-\ tumor\\:\\ 0\\.030378441312352702\ \(0\)\
\-\ other\\:\\ 0\\.030161113505783647\ \(0\)\
\-\ present\\:\\ 0\\.02980198050696969\ \(0\)\
\-\ exam\\:\\ 0\\.0292367614702669\ \(0\)\
\-\ demonstrates\\:\\ 0\\.029178022339116892\ \(0\)\
\-\ had\\:\\ 0\\.02893685944992817\ \(0\)\
\-\ contrast\\:\\ 0\\.02821917231704126\ \(0\)\
\-\ presents\\:\\ 0\\.027938771224233317\ \(0\)\
\-\ also\\:\\ 0\\.027318476413031603\ \(0\)\
\-\ within\\:\\ 0\\.02674918036700667\ \(0\)\
\-\ has\\:\\ 0\\.026528580617662327\ \(0\)\
\-\ which\\:\\ 0\\.026408885823575617\ \(0\)\
\-\ male\\:\\ 0\\.02585879610795166\ \(0\)\
\-\ disease\\:\\ 0\\.024379303987594487\ \(0\)\
\-\ be\\:\\ 0\\.023560138105328775\ \(0\)\
\-\ as\\:\\ 0\\.023332207064350876\ \(0\)\
\-\ are\\:\\ 0\\.022038161054909668\ \(0\)\
\-\ at\\:\\ 0\\.021936996350187185\ \(0\)\
\-\ or\\:\\ 0\\.02020448670804542\ \(0\)\
\-\ this\\:\\ 0\\.019956829102598307\ \(0\)\
\-\ no\\:\\ 0\\.01888647736685217\ \(0\)\
\-\ on\\:\\ 0\\.017540713213312218\ \(0\)\
